These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 219703)

  • 1. Myasthenia in frogs immunized against cholinergic-receptor protein.
    Nastuk WL; Niemi WD; Alexander JT; Chang HW; Nastuk MA
    Am J Physiol; 1979 Jan; 236(1):C53-7. PubMed ID: 219703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new test for myasthenia gravis: recording of miniature end-plate potentials in situ.
    Lovelace RE; Stone R; Zablow L
    Neurology; 1970 Apr; 20(4):385. PubMed ID: 5535003
    [No Abstract]   [Full Text] [Related]  

  • 3. Small mode miniature end plate potentials are increased and evoked in fatigued preparations and in high Mg2+ saline.
    Kriebel ME
    Brain Res; 1978 Jun; 148(2):381-8. PubMed ID: 207388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenia gravis animal model: quantitative analysis of the efficiency of pre- and postjunctional regions of intercostal muscles in rabbits immunized with Torpedo acetylcholine receptor.
    Albuquerque EX; Eldefrawi AT; Oliveira AC; Copio DS; Eldefrawi ME
    Exp Neurol; 1979 Oct; 66(1):109-22. PubMed ID: 225189
    [No Abstract]   [Full Text] [Related]  

  • 5. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
    Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A
    Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of myasthenic immunoglobulin G on neuromuscular transmission in mouse diaphragm.
    Chiu HC; Chen ML; Tsai MC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):217-23. PubMed ID: 2827968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental myasthenia due to alpha-bungarotoxin.
    Takamori M; Iwanaga S
    Neurology; 1976 Sep; 26(9):844-8. PubMed ID: 181695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Safety Factor for Neuromuscular Transmission: Effects of Dimethylsulphoxide, Cannabinoids and Synaptic Homeostasis.
    Odierna GL; Phillips WD
    J Neuromuscul Dis; 2021; 8(5):831-844. PubMed ID: 34334412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of prednisolone on neuromuscular transmission in normal rats and those with experimental autoimmune myasthenia gravis.
    Kim YI; Goldner MM; Sanders DB
    J Neurol Sci; 1979 Apr; 41(2):223-34. PubMed ID: 220391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and mechanism of neuromuscular block in myasthenia gravis.
    Grob D; Namba T
    Ann N Y Acad Sci; 1976; 274():143-73. PubMed ID: 183586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contribution of pre- and post-synaptic effects to the neostigmine-induced recovery of neuromuscular transmission blocked by vecuronium.
    Baso AC; Serra CS; Oliveira AC
    Fundam Clin Pharmacol; 2011 Feb; 25(1):123-30. PubMed ID: 20408882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
    Lindstrom J
    Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental autoimmune myasthenia gravis: the rabbit as an animal model.
    Eldefrawi ME
    Fed Proc; 1978 Dec; 37(14):2823-7. PubMed ID: 720635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of miniature end-plate potential amplitude in extraocular and limb muscles in an animal model of myasthenia gravis.
    Zahm DS; Kim YI; Liu HH; Johns TR
    Exp Neurol; 1983 Apr; 80(1):258-62. PubMed ID: 6832272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine receptor protein. Neuromuscular transmission in immunized rabbits.
    Elmqvist D; Mattsson C; Heilbronn E; Lundh H; Libelius R
    Arch Neurol; 1977 Jan; 34(1):7-11. PubMed ID: 188405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations.
    Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA
    J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia.
    Niks EH; Kuks JB; Wokke JH; Veldman H; Bakker E; Verschuuren JJ; Plomp JJ
    Muscle Nerve; 2010 Aug; 42(2):283-8. PubMed ID: 20544919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a monoclonal anti-acetylcholine receptor antibody on the avian end-plate.
    Maselli RA; Nelson DJ; Richman DP
    J Physiol; 1989 Apr; 411():271-83. PubMed ID: 2614725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interpretation of end plate potentials (EPP) and miniature end plate potentials (MEPP) by means of the Linc-8-computer, demonstrated with in vitro recordings from intercostal muscle of a patient with myasthenia gravis].
    Kruckenberg P; Bauer H
    Pflugers Arch; 1969; 307(2):R106. PubMed ID: 5814753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.